Dr. Hammond brings more than 15 years of exceptional expertise in clinical drug development, including the approval of medicines and beyond; he previously worked with the Astra Zeneca Group, where he took on increasing responsibilities, including Head of the Epidemiology Center of Excellence and leadership for the established brands, and for life cycle management within the respiratory franchise.

Dr. Hammond is a Physician-Scientist, Clinical Epidemiologist, and Public Health practitioner with biopharmaceutical industry and academic expertise, encompassing a strategic understanding of drug development and proven leadership. Dr. Hammond has successfully conceptualized and implemented several early and late-stage clinical trials and has been involved in successful drug development programs with approvals in the US and globally. Dr. Hammond’s focus has been an integrative, innovative, and efficient drug development continuum for which he has exceptional expertise spanning drug discovery, translational medicine, clinical trial design and analysis, medical affairs, pharmacovigilance, health outcomes, value propositioning and access strategies to facilitate deep understanding in support of drug development and post-marketing activities.